NKE
NIKE, Inc.
NKE has the edge over XPEV overall, supported by stronger valuation and lower modeled downside.
XPEV
XPeng Inc.
XPEV offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
XPEV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Unavailable |
XPEV's revenue and cash flow are currently stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
XPEV PE Valuation
XPEV has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
XPEV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
XPEV has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over XPEV on earnings quality, reporting a profit while its opponent remains loss making.
XPEV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.93 | -$0.25 |
| Q1 2026 | -$0.58 | +$0.23 |
| Q4 2025 | -$0.12 | +$0.80 |
| Q3 2025 | -$0.45 | +$0.47 |
| Q2 2025 | -$0.68 | +$0.63 |
| Q1 2025 | -$0.81 | +$0.79 |
| Q4 2024 | -$0.92 | +$0.87 |
| Q3 2024 | -$0.92 | +$1.07 |
XPEV is still losing money, but far less than before: $0.93 per share over the past year, against $1.99 at its worst in late 2023.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over XPEV on profitability, with a higher operating margin.
XPEV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3B | +7.7% |
| Q1 2026 | $1.9B | -18% |
| Q4 2025 | $3.3B | +36% |
| Q3 2025 | $3.1B | +102% |
| Q2 2025 | $2.7B | +125% |
| Q1 2025 | $2.4B | +141% |
| Q4 2024 | $2.4B | +23% |
| Q3 2024 | $1.5B | +18% |
XPEV has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -6.7% | -1.6 points |
| Q1 2026 | -16% | -9.6 points |
| Q4 2025 | -4.2% | +5.5 points |
| Q3 2025 | -3.7% | +15 points |
| Q2 2025 | -5.1% | +15 points |
| Q1 2025 | -6.6% | +19 points |
| Q4 2024 | -9.7% | +6.1 points |
| Q3 2024 | -18% | +19 points |
XPEV's operating margin was −6.7% last quarter, down 1.6 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over XPEV on cash flow, with more consistent year-over-year improvement.
XPEV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
XPEV's free cash flow was $0 over the past year, against $0 the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
XPEV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +541K shares |
| 1 year | -49% | -467M shares |
| 3 years | -45% | -383M shares |
| 5 years | -44% | -377M shares |
| Available history | -44% | -377M shares |
XPEV has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
XPEV hasn't bought back shares in the past year.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
XPEV Net Leverage
XPEV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
XPEV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 17.7 | Oversold |
XPEV's weekly RSI is 36 (neutral) and its Stochastic is 18 (oversold).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
XPEV PE vs Consumer Cyclical Sector
XPEV has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over XPEV on trend strength, trading above more of its moving averages.
XPEV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.56 | 1% below |
| 20 week MA | $11.1 | 14% below |
| 50 week MA | $14.9 | 37% below |
| 100 week MA | $17.2 | 45% below |
| 200 week MA | $14.2 | 33% below |
XPEV is in a downtrend: it's below all five of its weekly moving averages, and 33% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over XPEV on returns for 2026, with the stronger performance.
XPEV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $41.9 | +84% |
| 2021 | $41.9 | $46.1 | +10% |
| 2022 | $46.1 | $10.1 | -78% |
| 2023 | $10.1 | $14.6 | +45% |
| 2024 | $14.6 | $12.6 | -13% |
| 2025 | $12.6 | $20.8 | +65% |
| 2026 YTD | $20.8 | $9.46 | -54% |
XPEV is down 54% so far in 2026, after finishing higher in four of the previous six years.